Subscribe to Newsletter
Business & Regulation Business Practice, Facilities

For the Love of the North

For SMEs and start-ups, getting their feet off the ground can be an uphill battle and a lack of access to financing and resources can make it difficult for them to realize success. Cytiva hopes to support young companies via a new open access lab at Alderley Park’s Mereside Campus in Cheshire, granting access to advanced protein and cell analysis technologies (including ÄKTA systems for protein purification, Biacore 8K for drug discovery, and IN Cell Analyzer 6500HS for cellular imaging), as well as Cytiva’s onsite and online training.

“Start-ups and emerging biotechnology companies have a critical role to play in pharma,” said Conor McKechnie, Chief Marketing Officer at Cytiva. “They have a reputation for transcending organizational boundaries, which is something larger companies can learn from.”

McKechnie went on to explain that the partnership with Alderley Park aimed to not only support SMEs and start-ups in gaining access to valuable technologies, but also, on a more broad scale, to identify the challenges SMEs face and opportunities to collaborate on solutions that will benefit the UK’s life sciences community as a whole. Northern England is one of the top five locations for R&D in the UK (with a 42 percent increase in investment in  biotechnology companies since 2016), but much of the scientific community remains fixed on the south in locations such as Oxford, Cambridge and London.

“Given the regional growth of the industry, Alderley Park is a great strategic location for this lab,” McKechnie commented. “But we are also committed to the UK biotech start-up community outside of the North through our open access lab at the Stevenage BioScience Catalyst (SBC) in Hertfordshire, and online through our collaboration with the equipment sharing marketplace, Clustermarket.”

To date, 28 companies have expressed interest in using the lab space. 
 

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Maryam Mahdi

Deputy Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register